J Intern Med; auth.: B.Thorens

J Intern Med. 2013 Jun 10. doi: 10.1111/joim.12096. [Epub ahead of print]

The required beta cell research for improving treatment of type 2 diabetes.


Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.


In healthy individuals, insulin resistance is associated with physiological conditions such as pregnancy or body weight gain and triggers an increase in beta cell number and insulin secretion capacity to preserve normoglycaemia. Failure of this beta cell compensation capacity is a fundamental cause of diabetic hyperglycaemia. Incomplete understanding of the molecular mechanisms controlling the plasticity of adult beta cell mechanisms and how these cells fail during the pathogenesis of diabetes strongly limits the ability to develop new beta cell-specific therapies. Here, current knowledge of the signalling pathways controlling beta cell plasticity is reviewed and possible directions for future research are discussed. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved.